HLCM051

BIOLOGICAL2 trials

Sponsors

Healios K.K.

Conditions

Respiratory Distress Syndrome, AdultStroke, Acute

Phase 2

Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements

CompletedNCT02961504

Healios K.K.Stroke, Acute

Start: 2017-11-15End: 2023-02-28Updated: 2024-01-17

Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome

CompletedNCT03807804

Healios K.K.Respiratory Distress Syndrome, Adult

Start: 2019-01-01End: 2021-12-14Updated: 2024-01-17

Related Papers

Allogeneic Stem Cell Therapy for Acute Ischemic Stroke

JAMA Neurology2024-01-1649 citations

Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy–controlled, phase 2 multicenter study (ONE-BRIDGE)

Stem Cell Research & Therapy2023-08-2217 citations

Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design

International Journal of Stroke2017-11-1422 citations